Drug-drug interaction profile of the all-oral anti-hepatitis C virus regimen of paritaprevir/ritonavir, ombitasvir, and dasabuvir
Menon, Rajeev M, Badri, Prajakta S, Wang, Tianli, Polepally, Akshanth R, Zha, Jiuhong, Khatri, Amit, Wang, Haoyu, Hu, Beibei, Coakley, Eoin P, Podsadecki, Thomas J, Awni, Walid M, Dutta, Sandeep
Published in Journal of hepatology (01.07.2015)
Published in Journal of hepatology (01.07.2015)
Get full text
Journal Article
Pharmacokinetics of Tacrolimus and Cyclosporine in Liver Transplant Recipients Receiving 3 Direct-Acting Antivirals as Treatment for Hepatitis C Infection
Badri, Prajakta S, Parikh, Apurvasena, Coakley, Eoin P, Ding, Bifeng, Awni, Walid M, Dutta, Sandeep, Menon, Rajeev M
Published in Therapeutic drug monitoring (01.10.2016)
Published in Therapeutic drug monitoring (01.10.2016)
Get more information
Journal Article
Pharmacokinetics and safety of co-administered paritaprevir plus ritonavir, ombitasvir, and dasabuvir in hepatic impairment
Khatri, Amit, Menon, Rajeev M, Marbury, Thomas C, Lawitz, Eric J, Podsadecki, Thomas J, Mullally, Victoria M, Ding, Bifeng, Awni, Walid M, Bernstein, Barry M, Dutta, Sandeep
Published in Journal of hepatology (01.10.2015)
Published in Journal of hepatology (01.10.2015)
Get full text
Journal Article
Impact of Venetoclax Exposure on Clinical Efficacy and Safety in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
Freise, Kevin J., Jones, Aksana K., Eckert, Doerthe, Mensing, Sven, Wong, Shekman L., Humerickhouse, Rod A., Awni, Walid M., Salem, Ahmed Hamed
Published in Clinical pharmacokinetics (01.05.2017)
Published in Clinical pharmacokinetics (01.05.2017)
Get full text
Journal Article
Clinical Pharmacokinetics of Paritaprevir
Menon, Rajeev M., Polepally, Akshanth R., Khatri, Amit, Awni, Walid M., Dutta, Sandeep
Published in Clinical pharmacokinetics (01.10.2017)
Published in Clinical pharmacokinetics (01.10.2017)
Get full text
Journal Article
Pharmacokinetics and exposure-efficacy relationship of adalimumab in pediatric patients with moderate to severe Crohn's disease: results from a randomized, multicenter, phase-3 study
Sharma, Shringi, Eckert, Doerthe, Hyams, Jeffrey S, Mensing, Sven, Thakkar, Roopal B, Robinson, Anne M, Rosh, Joel R, Ruemmele, Frank M, Awni, Walid M
Published in Inflammatory bowel diseases (01.04.2015)
Published in Inflammatory bowel diseases (01.04.2015)
Get full text
Journal Article
Effects of the TRPV1 antagonist ABT‐102 on body temperature in healthy volunteers: pharmacokinetic/ pharmacodynamic analysis of three phase 1 trials
Othman, Ahmed A., Nothaft, Wolfram, Awni, Walid M., Dutta, Sandeep
Published in British journal of clinical pharmacology (01.04.2013)
Published in British journal of clinical pharmacology (01.04.2013)
Get full text
Journal Article
Methotrexate Dose in Patients With Early Rheumatoid Arthritis Impacts Methotrexate Polyglutamate Pharmacokinetics, Adalimumab Pharmacokinetics, and Efficacy: Pharmacokinetic and Exposure-response Analysis of the CONCERTO Trial
Goss, Sandra L., Klein, Cheri E., Jin, Ziyi, Locke, Charles S., Rodila, Ramona C., Kupper, Hartmut, Burmester, Gerd-Rudiger, Awni, Walid M.
Published in Clinical therapeutics (01.02.2018)
Published in Clinical therapeutics (01.02.2018)
Get full text
Journal Article
Drug Interactions with the Direct-Acting Antiviral Combination of Ombitasvir and Paritaprevir-Ritonavir
Badri, Prajakta S, Dutta, Sandeep, Wang, Haoyu, Podsadecki, Thomas J, Polepally, Akshanth R, Khatri, Amit, Zha, Jiuhong, Chiu, Yi-Lin, Awni, Walid M, Menon, Rajeev M
Published in Antimicrobial agents and chemotherapy (01.01.2016)
Published in Antimicrobial agents and chemotherapy (01.01.2016)
Get full text
Journal Article
Industry Perspective on Standardizing Food-Effect Studies for New Drug Development
Marroum, Patrick J., Nuthalapati, Silpa, Parikh, Apurvasena, Shebley, Mohamad, Hoffman, David, Zha, Jiuhong, Khatri, Amit, Awni, Walid M.
Published in Clinical pharmacokinetics (01.08.2018)
Published in Clinical pharmacokinetics (01.08.2018)
Get full text
Journal Article
Relationship between venetoclax exposure, rituximab coadministration, and progression‐free survival in patients with relapsed or refractory chronic lymphocytic leukemia: demonstration of synergy
Freise, Kevin J., Jones, Aksana K., Menon, Rajeev M., Verdugo, Maria E., Humerickhouse, Rod A., Awni, Walid M., Salem, Ahmed Hamed
Published in Hematological oncology (01.12.2017)
Published in Hematological oncology (01.12.2017)
Get full text
Journal Article
Pharmacokinetics and Tolerability of Anti-Hepatitis C Virus Treatment with Ombitasvir, Paritaprevir, Ritonavir, with or Without Dasabuvir, in Subjects with Renal Impairment
Khatri, Amit, Dutta, Sandeep, Marbury, Thomas C., Preston, Richard A., Rodrigues, Lino, Wang, Haoyu, Awni, Walid M., Menon, Rajeev M.
Published in Clinical pharmacokinetics (01.02.2017)
Published in Clinical pharmacokinetics (01.02.2017)
Get full text
Journal Article
Drug-Drug Interactions between Sofosbuvir and Ombitasvir-Paritaprevir-Ritonavir with or without Dasabuvir
King, Jennifer R, Dutta, Sandeep, Cohen, Daniel, Podsadecki, Thomas J, Ding, Bifeng, Awni, Walid M, Menon, Rajeev M
Published in Antimicrobial agents and chemotherapy (01.02.2016)
Published in Antimicrobial agents and chemotherapy (01.02.2016)
Get full text
Journal Article
Relationship Between Atrasentan Concentrations and Urinary Albumin to Creatinine Ratio in Western and Japanese Patients With Diabetic Nephropathy
Lin, Chih-Wei, Mostafa, Nael M., L. Andress, Dennis, J. Brennan, John, Klein, Cheri E., Awni, Walid M.
Published in Clinical therapeutics (01.02.2018)
Published in Clinical therapeutics (01.02.2018)
Get full text
Journal Article
Population pharmacokinetics of paritaprevir, ombitasvir, dasabuvir, ritonavir and ribavirin in hepatitis C virus genotype 1 infection: analysis of six phase III trials
Mensing, Sven, Eckert, Doerthe, Sharma, Shringi, Polepally, Akshanth R., Khatri, Amit, Podsadecki, Thomas J., Awni, Walid M., Menon, Rajeev M., Dutta, Sandeep
Published in British journal of clinical pharmacology (01.03.2017)
Published in British journal of clinical pharmacology (01.03.2017)
Get full text
Journal Article
Dose- and Formulation-Dependent Non-Linear Pharmacokinetic Model of Paritaprevir, a Protease Inhibitor for the Treatment of Hepatitis C Virus Infection: Combined Analysis from 12 Phase I Studies
Polepally, Akshanth R., Mensing, Sven, Khatri, Amit, Beck, Denise, Liu, Wei, Awni, Walid M., Menon, Rajeev M., Dutta, Sandeep
Published in Clinical pharmacokinetics (01.09.2016)
Published in Clinical pharmacokinetics (01.09.2016)
Get full text
Journal Article
Population Pharmacokinetics of Paritaprevir, Ombitasvir, Dasabuvir, Ritonavir, and Ribavirin in Patients with Hepatitis C Virus Genotype 1 Infection: Combined Analysis from 9 Phase 1b/2 Studies
Mensing, Sven, Polepally, Akshanth R., König, Denise, Khatri, Amit, Liu, Wei, Podsadecki, Thomas J., Awni, Walid M., Menon, Rajeev M., Dutta, Sandeep
Published in The AAPS journal (01.01.2016)
Published in The AAPS journal (01.01.2016)
Get full text
Journal Article
Drug-Drug Interaction of Omeprazole With the HCV Direct-Acting Antiviral Agents Paritaprevir/Ritonavir and Ombitasvir With and Without Dasabuvir
Polepally, Akshanth R., Dutta, Sandeep, Hu, Beibei, Podsadecki, Thomas J., Awni, Walid M., Menon, Rajeev M.
Published in Clinical pharmacology in drug development (01.07.2016)
Published in Clinical pharmacology in drug development (01.07.2016)
Get full text
Journal Article